Lawrence P. Wennogle, Vice President, Drug Discovery at Intra-Cellular Therapies, Inc. (ITCI), sold 16,499 shares at $15.00 ($247K) on 2014-10-06, disclosed to the SEC on 2014-10-07.
Scheduled sale ($247k) by Vice President, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 15,863 | $238K | 96.1% |
| 2 | $15.00 | 636 | $10K | 3.9% |
| Total | $15.00 avg | 16,499 | $247K | 100% |
| Filing → |
| ITCI | SELL | 2014-10-15 | $54K | — | Filing → |
| ITCI | SELL | 2014-10-10 | $71K | — | Filing → |
| ITCI | SELL | 2014-09-17 | $75K | — | Filing → |